{"asset":{"id":"3953ea0c-a910-464b-85fe-ac60e5c46a65","symbol":"A","name":"Agilent Technologies","asset_type":"stock","exchange":"US","country":"US","currency":"USD","sector":"Health Care","industry":"Life Sciences Tools & Services","crypto_category":null,"coingecko_id":null,"is_active":true,"created_at":"2026-11-16T20:38:59.474331+00:00","updated_at":"2026-11-16T20:38:59.474331+00:00"},"latest_value_score":{"id":17,"asset_id":"3953ea0c-a910-464b-85fe-ac60e5c46a65","score_date":"2026-11-18","value_score":16.444183999999996,"value_component":16.444183999999996,"quality_component":87.68275175,"risk_component":87.80779999999999,"valuation_status":"weak","quality_status":"strong","risk_status":"strong","value_trap_flag":false,"margin_of_safety":null,"fair_value_low":null,"fair_value_mid":null,"fair_value_high":null,"score_breakdown":{"risk":{"leverage_score":0.96832,"liquidity_score":1.0,"volatility_score":0.6358333333333333},"value":{"pb_score":0.0,"pe_score":0.04126239999999992,"dividend_score":1.0,"ev_ebitda_score":0.0},"quality":{"roe_score":1.0,"growth_score":0.54,"margin_score":0.9766500499999999},"raw_metrics":{"beta":1.237,"ev_ebitda":24.492,"forward_pe":25.635147,"net_margin":0.19533001,"trailing_pe":33.96844,"current_ratio":2.05,"price_to_book":6.5951824,"debt_to_equity":56.336,"dividend_yield":0.59,"revenue_growth":0.081,"operating_margin":0.24539,"return_on_equity":0.20971}},"created_at":"2026-11-18T08:00:41.725285+00:00"},"latest_ranking":{"id":"20096630-0c9d-4235-b589-0f54e3eeadca","asset_id":"3953ea0c-a910-464b-85fe-ac60e5c46a65","ranking_date":"2026-11-18","overall_score":38.26919289058642,"value_component":16.444183999999996,"quality_component":87.68275175,"risk_component":12.192200000000014,"technical_component":30.648148148148145,"news_component":34.5679012345679,"opportunity_type":"watchlist","rank":94,"rationale":{"news_bias":-0.308641975308642,"technical":"Signal: reduce, confidence: 43.8","asset_type":"stock","components":{"news_component":34.5679012345679,"risk_component":12.192200000000014,"value_component":16.444183999999996,"quality_component":87.68275175,"technical_component":30.648148148148145,"value_trap_penalty_applied":false},"news_strength":1.0,"value_trap_flag":false,"articles_analyzed":10},"created_at":"2026-11-18T08:06:24.207715+00:00","updated_at":"2026-11-18T08:06:24.207715+00:00"},"latest_signal":{"id":"fc5f12f0-aba2-46e2-b41f-ef8014d3129a","asset_id":"3953ea0c-a910-464b-85fe-ac60e5c46a65","signal_date":"2026-11-18T07:56:35.093411+00:00","signal_type":"tactical","action":"reduce","confidence":43.82716049382716,"entry_price":172.22000122070312,"entry_zone_low":167.20928628104073,"entry_zone_high":177.23071616036552,"stop_loss":162.19857134137834,"target_1":182.2414311000279,"target_2":187.25214603969027,"risk_reward_ratio":1.0,"position_size_pct":2.0,"time_horizon":"days_to_weeks","invalidation_level":162.19857134137834,"summary":"Fused signal based on technical setup and 10 recent news articles. News bias: -0.31, news strength: 1.00.","status":"active","created_at":"2026-11-18T07:06:18.835371+00:00","updated_at":"2026-11-18T07:56:35.093449+00:00","engine_version":null,"price_as_of":null,"price_fetched_at":null,"price_basis":null,"reference_price":null,"technical_score":null,"calculation_metadata":null},"signal_reasons":[{"id":82,"signal_id":"fc5f12f0-aba2-46e2-b41f-ef8014d3129a","category":"news","reason":"Negative recent news weakens the existing technical setup | High news impact detected | Technical confidence: 50.00 | News bias: -0.31 | News strength: 1.00 | Fused confidence: 43.83 | Recent articles analyzed: 10 | Previous technical action: hold","impact":"negative","weight":1.0,"source":"Finnhub news ingestion; 10 articles analyzed","created_at":"2026-11-18T07:56:35.397402+00:00"}],"recent_news":[{"id":77,"asset_id":"3953ea0c-a910-464b-85fe-ac60e5c46a65","published_at":"2026-11-17T17:03:38+00:00","title":"A $6.2 Billion Hedge Fund Dumps These 2 Stocks","url":"https://finnhub.io/api/news?id=4fe5acd1fa31534138336425b9d0f12bc4a0ad5c68cad71c02e85c24578191f6","source":"Yahoo","category":"company_news","sentiment":0.0,"impact_score":0,"relevance_score":1.0,"summary":"Key TakeawaysValueAct Capital’s latest 13F shows it sold all of its Roblox and CBRE shares in the third quarter. Roblox has guided fourth-quarter bookings down 10% to 15%, and analysts’ average target is down about two-thirds in a year.","created_at":"2026-11-18T07:12:19.002759+00:00"},{"id":78,"asset_id":"3953ea0c-a910-464b-85fe-ac60e5c46a65","published_at":"2026-11-17T12:38:58+00:00","title":"Has The Story Under Bruker Stock Run Out?","url":"https://finnhub.io/api/news?id=cb978fa4995ef9a28d1276f93f35e23969ca35b35a89f987e2e7fe071600e417","source":"Yahoo","category":"company_news","sentiment":0.0,"impact_score":0,"relevance_score":1.0,"summary":"Today's big story: Could Nvidia Stock Fall 50%? Follow The Cash.","created_at":"2026-11-18T07:12:19.10534+00:00"},{"id":79,"asset_id":"3953ea0c-a910-464b-85fe-ac60e5c46a65","published_at":"2026-11-17T02:53:18+00:00","title":"What Was Waters Telling You Before Its Stock Ran?","url":"https://finnhub.io/api/news?id=79034aa8d47c2592f502a6bad3de95a9166b18992e53d28d9a73367a4d6e0c76","source":"Yahoo","category":"company_news","sentiment":0.0,"impact_score":0,"relevance_score":1.0,"summary":"For questions about this article or underlying research, email help@trefis.com.","created_at":"2026-11-18T07:12:19.210661+00:00"},{"id":80,"asset_id":"3953ea0c-a910-464b-85fe-ac60e5c46a65","published_at":"2026-11-17T01:00:01+00:00","title":"NRx Pharmaceuticals, Inc. (NRXP) Reports Q3 Loss, Misses Revenue Estimates","url":"https://finnhub.io/api/news?id=400a024f70e8a1b3454cf55d347b9ac17c717e5c5e389cebfaaf10cebf969c9e","source":"Yahoo","category":"earnings","sentiment":-1.0,"impact_score":3,"relevance_score":1.0,"summary":"NRx Pharmaceuticals (NRXP) delivered earnings and revenue surprises of +82.76% and -14.15%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?","created_at":"2026-11-18T07:12:19.316874+00:00"},{"id":81,"asset_id":"3953ea0c-a910-464b-85fe-ac60e5c46a65","published_at":"2026-11-16T16:00:02+00:00","title":"Agilent Technologies (A) Reports Next Week: Wall Street Expects Earnings Growth","url":"https://finnhub.io/api/news?id=a780610c5695e245a3adc99e4357a295b45e5f37dc8cea0b239548c250d5bf98","source":"Yahoo","category":"earnings","sentiment":0.6666666666666666,"impact_score":2,"relevance_score":1.0,"summary":"Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.","created_at":"2026-11-18T07:12:19.419339+00:00"},{"id":82,"asset_id":"3953ea0c-a910-464b-85fe-ac60e5c46a65","published_at":"2026-11-13T14:08:53+00:00","title":"Keith Meister Sells $61M Of Illumina Stock As Shares Slip Below Sale Price","url":"https://finnhub.io/api/news?id=9da3d117bbf389ddcd7bb98f8d8e72392a568d338e629f22392ac59495d52e69","source":"Benzinga","category":"company_news","sentiment":0.0,"impact_score":0,"relevance_score":1.0,"summary":"Keith Meister, who controls the general partner of Corvex Management, sold 280,091 shares of Illumina Inc (NASDAQ:ILMN) for $61.1 million on Nov. 9, 2026.Illumina shares were $208.85 on Friday, 4.25% below the $218.12","created_at":"2026-11-18T07:12:19.522562+00:00"},{"id":83,"asset_id":"3953ea0c-a910-464b-85fe-ac60e5c46a65","published_at":"2026-11-13T00:12:23+00:00","title":"Agilent Technologies (A) Launches New Cancer Panel As Valuation Stays In Focus","url":"https://finnhub.io/api/news?id=ac849c77df2607d7e6087baac1bea813882a451f30b40b9f35b08ae8b14fc8aa","source":"Yahoo","category":"company_news","sentiment":0.0,"impact_score":0,"relevance_score":1.0,"summary":"Agilent Technologies (A) has broadened its cancer research toolkit with the SureSelect Cancer Research Pan Heme panel, a next generation sequencing solution tailored to genomic profiling of blood related tumors. Recent product launches in genomic profiling and mass spectrometry are landing against a strong share price backdrop for Agilent Technologies, with the stock at US$176.95. Short term momentum is building, with a 30 day share price return of 3.28% and a 90 day share price return of...","created_at":"2026-11-18T07:12:19.625091+00:00"},{"id":84,"asset_id":"3953ea0c-a910-464b-85fe-ac60e5c46a65","published_at":"2026-11-12T23:15:00+00:00","title":"Agilent to Participate in 9th Annual Evercore Healthcare Conference","url":"https://finnhub.io/api/news?id=ea31356e2eaddb688846820c8d5802ba395847625a30275c67262cb80f34b7d7","source":"Yahoo","category":"company_news","sentiment":0.0,"impact_score":0,"relevance_score":1.0,"summary":"SANTA CLARA, Calif., November 12, 2026--Agilent Technologies Inc. (NYSE: A) today announced that the company will participate in the upcoming 9th Annual Evercore Healthcare Conference. Agilent management is scheduled to participate in a fireside chat from 10 a.m. to 10:50 a.m. EST on Tuesday, Dec. 1, 2026, in Coral Gables, Florida. A live audio webcast and replay of the presentation will be available through Agilent’s Investor Relations website.","created_at":"2026-11-18T07:12:19.727675+00:00"},{"id":85,"asset_id":"3953ea0c-a910-464b-85fe-ac60e5c46a65","published_at":"2026-11-12T20:55:54+00:00","title":"What Happened To People Who Bought Thermo Fisher Stock At A High?","url":"https://finnhub.io/api/news?id=205d74be87166fe9dcad0eadda3f5fa5b8c396aab6a6fa941fdf102da05449fb","source":"Yahoo","category":"company_news","sentiment":0.0,"impact_score":0,"relevance_score":1.0,"summary":"For questions about this article or underlying research, email help@trefis.com.","created_at":"2026-11-18T07:12:19.828464+00:00"},{"id":86,"asset_id":"3953ea0c-a910-464b-85fe-ac60e5c46a65","published_at":"2026-11-12T19:12:46+00:00","title":"Learn Why The Bull Case For Agilent Stock Could Change Following Pan Heme Launch","url":"https://finnhub.io/api/news?id=6287d1b111738bf4000a295c2d596e48863baa459c82cd2cfc745fd0b0c9d613","source":"Yahoo","category":"company_news","sentiment":0.0,"impact_score":0,"relevance_score":1.0,"summary":"Agilent Technologies recently introduced the SureSelect Cancer Research Pan Heme, a hybrid capture NGS panel that integrates DNA and RNA profiling, automation and bioinformatics to study 359 DNA genes and 124 RNA genes in hematologic malignancy research. The new panel, codeveloped with Roswell Park Comprehensive Cancer Center and designed for a roughly 48 hour sample to report workflow, deepens Agilent Technologies' focus on comprehensive, workflow based cancer research solutions rather than...","created_at":"2026-11-18T07:12:19.932653+00:00"}]}